Patients Validating medications: A consumer responsibility? Access to medications is a vital aspect of maintaining healthy lives, and the urge to invest in personal health has only grown since the COVID-19 pandemic.
Partner Content Partner Content KOL Validation: An Opportunity To Benchmark Mindset The benefits of conducting a regular KOL validation exercise to refresh your KOL list are well established.
Partner Content Partner Content Experts to come together for compliance event Experts to come together for compliance event
Partner Content Partner Content Validating Your KOLs Validating your KOLs for an evolving KOL landscape
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.